Portable blood gas analyzers areintended for use in testing at patient bedside. Portable POC blood gasanalyzers are easy to transport and are most cost effective in units with a lowtest volume per day. Portable analyzers require the least maintenance comparedto other types.
EMEBlood Gas and Electrolyte Analyzers Market is estimated to account for US$139.4 Mn in terms of value in 2020 and is expected to reach US$ 195.7 Mn in termsof value by the end of 2027.
EME Blood Gas and ElectrolyteAnalyzers Market: Drivers
Approval and launch of newdevices is expected to propel growth of EME blood gas and electrolyte analyzersmarket over the forecast period. For instance, in March 2020, SiemensHealthineers received the U.S. Food and Drug Administration clearance for itsRapidPoint 500e blood gas analyzer for diagnosing and monitoring people in theintensive care unit, operating room or emergency room.
EME Blood Gas and Electrolyte AnalyzersMarket: Opportunities
Launch of digital solutions isexpected to offer lucrative growth opportunities for players in EME blood gasand electrolyte analyzers market. For instance, in May 2020, F. Hoffmann-LaRoche Ltd. launched Roche v-TAC, a digital diagnostic solution that allowsclinicians to obtain results for arterial blood gas values from patients withrespiratory or metabolic abnormalities.
EME Blood Gas and ElectrolyteAnalyzers Market: Restraints
Product recall is expected tohinder the market growth. For instance, in August 2019, Radiometer America Inc.recalled ABL90 FLEX Analyzer, owing to software security vulnerabilities.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/3971
Key Takeaways:
EME blood gas and electrolyteanalyzers market was valued at US$ 133.2 Mn in 2019 and is forecast to reach avalue of US$ 195.7 Mn by 2027 at a CAGR of 5.0% between 2020 and 2027. Majorfactor driving the growth of EME blood gas and electrolyte analyzers marketduring the forecast period include increasing prevalence of chronic disorders,and product launches.
Laboratory analyzers helddominant position in EME blood gas and electrolyte analyzers market in 2019,accounting for 38.1% share in terms of value, followed by benchtop analyzersand portable analyzers, respectively. Centralized laboratories utilize bloodgas and electrolyte analyzers on a large basis. Since, point of care testing isnot highly used in these regions, laboratory analyzers are expected to witnessgrowth over the forecast period.
Market Trends
Major players in the market arefocused on approval and launch of new products to expand their productportfolio. For instance, in May 2020, Abbott Laboratories received EmergencyUse Authorization from the US Food and Drug Administration (FDA) for the company'smolecular test for COVID-19 for use on its new Alinity m molecular laboratoryinstrument.
Major players in the market arealso focused on adopting partnership strategies to enhance their market share.For instance, in May 2020, EKF Diagnostics signed a three-year distributionagreement with Tosoh Europe N.V. for the distribution of its Quo-Test HbA1cpoint-of-care analyzer in the Middle East and Africa.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/eme-blood-gas-and-electrolyte-analyzers-market-3971
Regulations
Middle East
There are two government bodies,SGK and MOh, in Turkey which are involved in reimbursing healthcare expensesincurred by healthcare institutions such as hospitals. SGK reimburses expensessuffered by using the treatment type and medical device listed in theHealthcare Implementation Communique (SUT).
National legislation regardingmedical device regulation in Turkey has been aligned with that of the EU.
EME Blood Gas and ElectrolyteAnalyzers Market: Competitive Landscape
Major players operating in EMEblood gas and electrolyte analyzers market include, Abbott Laboratories, MedicaCorporation, Nova Biomedical, Radiometer Medical ApS, F. Hoffmann-La RocheLtd., Siemens Healthcare, Alere Inc., EKF Diagnostics, ERBA DiagnosticsMannheim GmbH, and Instrumentation Laboratories (Werfen).
EME Blood Gas and Electrolyte AnalyzersMarket: Key Developments
April 2020: DiaSorin Inc.completed studies to support the launch of a new serological andhigh-processing volume test for detecting the presence of antibodies in patientsinfected with the SARS-CoV-2.
January 2020: Abbott Laboratorieswarned customers to discontinue use of its i-Stat Blue Chem8+ and CG4+ bloodanalysis cartridges
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/3971
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
